Sales and Marketing

The national shortage of HRT products could have an impact on some women, who may not be able to sleep …

Novo Nordisk has announced that the EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion …

Preliminary results from an ongoing nationwide health needs assessment, conducted by WHO in partnership with Premise, indicate that one in …

Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …

A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …

World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …

A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in …

The FDA has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab), in patients aged 12 …

The new Centre for Protein Degradation has been launched, made possible by a £9 million donation to The Institute of …

Parents and carers of five to 11-year olds in England can now book a low-dose COVID-19 vaccine for their children. …

NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …

UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …

CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …